A better world
FAIL-SAFE INFUSION
The CYTO360 IV-set
IV -set on the market today allows unintentional mixing of drug fluids when secondary infusions accidentally are administrating in parallel.
The "CYTO360 medical stopcock" is a multigang manifold in turn-valve configuration. Forcing multiple secondary infusions to be administered in series.
Administration error
Mission: Risk prevention of IV -set with a fail-safe design
Human factors
Administration error related to open and closing drug flow to the patient probably follow the same error rate as standardized by human factors experts. Humans make 1 error per 100 actions. Administration errors occur probably more often then we think. If your IV -set allows more then one drug flow to the patient then it is likely that administration errors happens daily already with your IV -set or stopcock arrangements (multigang manifolds).
"My innovation CYTO360 is probably a direct result of my interests in human factors and seeing the problem in a different way. As an airline pilot you are always making mistakes, because they are so many mistakes to be done. And so it is for all workplaces not least at a hospital. Whenever possible we must have fail-safe infusion system to catch these errors" - Micael Törnblom
Continues drug incompatibility
Mission: Reduce the risk of mixing drugs when administrating infusion
COCKTAIL EFFECT
Most infusion treatments never require multiple drug infusion at the same time. In fact there is a great risk with unintentionally mixing drugs. It is called “drug incompatibility” and can cause a cocktail effect, with enhanced or reduced effect of the drug or even a new compound can form with no knowledge of its effect.
CYTO360 VIDEO
Request access by filling in the form below or send an e-mail to info@cyto365.com
The CYTO360 medical stopcock by CYTO365 AB has been awarded 1st price of Venturecup and nominated to Alfred Nobel SKAPA stiftelse 2012.
In cooperation with AWA Patent, ALMI and proved trackrecord with one of the world largest medtech company.
Patent granted
PROTECTED IN 148 COUNTRIES
IP partner
Business Partner
Awards
Awards
LICENSE OF PATENTS
There are 22 countries listed already by a global medtech company for exclusive rights to manufacture and sell the CYTO360 medical stopcock including main parts of Europe, Australia, Russia and China.However there are still high valued markets available such as; North America, Japan, Eurasia, Africa, the Middle East and India to name a few.
Contact us for more information on how you can be non exclusive or exclusive distributor or manufacturer of the CYTO360 medical stopcock valve.
COMMUNICATIONS
CYTO365 AB, C/O Micael Törnblom, Bergstensgatan 2, 263 65 Viken, Sweden
CYTO365
CYTO365 is a distruptive startup that innovates fail-safe medical devices
CONTACT FORM
Make a request today for more information
© 2016 CYTO365 AB
Legal notice: Any information found on this website may not be copied and/ or distributed to third party without prior notice from CYTO365 AB.
CYTO365 AB can not be hold responsible for any possible harm caused by the content on this website.
The information is not intended as guidelines for medical use.